- Home
- RNAC vs KPET Comparison
RNAC vs KPET Comparison
Compare RNAC & KPET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNAC | KPET |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 283.2M | 287.8M |
| IPO Year | 2016 | 2026 |
Fundamental Metrics
Financial Performance| Metric | RNAC | KPET |
|---|---|---|
| Price | $10.53 | $9.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | ★ 486.6K | 23.3K |
| Earning Date | 05-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,797,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.60 | $9.95 |
| 52 Week High | $14.56 | $10.01 |
Technical Indicators
Market Signals| Indicator | RNAC | KPET |
|---|---|---|
| Relative Strength Index (RSI) | 64.43 | N/A |
| Support Level | $6.14 | N/A |
| Resistance Level | $11.00 | N/A |
| Average True Range (ATR) | 1.03 | 0.00 |
| MACD | 0.11 | 0.00 |
| Stochastic Oscillator | 84.68 | 0.00 |
Price Performance
Historical ComparisonAbout RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
About KPET KPET Ultra Paceline Corporation Class A Ordinary Shares
KPET Ultra Paceline Corp is a Blank Check company. It is formed with the objective of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.